Ebru Evren
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antifungal resistance and susceptibility 5
- SARS-CoV-2 and COVID-19 Research 4
- SARS-CoV-2 detection and testing 3
-
- Antibiotic Resistance in Bacteria 5
- Co-authors
- Erkan Yurtçu (1 shared paper)Hande Arslan (2 shared papers)Şule Çolakoğlu (1 shared paper)Özlem Kurt Azap (2 shared papers)Zeynep Ceren Karahan (10 shared papers)Alper Tekelı (2 shared papers)İştar Dolapçı (2 shared papers)Müge Demirbilek (1 shared paper)
- Journals
- Journal of Materials Chemistry B (1 paper)Eye & Contact Lens Science & Clinical Practice (1 paper)Journal of Infection (1 paper)Analytical Chemistry (1 paper)Scandinavian Journal of Infectious Diseases (1 paper)
- Partner nations
- TürkiyeUnited StatesBelgium
In The Last Decade
Ebru Evren
27 papers receiving 288 citations
Peers
Comparison fields: 5 of 68
- Molecular Medicine 77
- Applied Microbiology and Biotechnology 23
- Microbiology 5
- Infectious Diseases 109
- Pharmacology 44
Countries citing papers authored by Ebru Evren
This map shows the geographic impact of Ebru Evren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ebru Evren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ebru Evren more than expected).
Fields of papers citing papers by Ebru Evren
This network shows the impact of papers produced by Ebru Evren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ebru Evren. The network helps show where Ebru Evren may publish in the future.
Co-authors
The 25 scholars most cited alongside Ebru Evren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 75 | |
| 2 | 2013 | 43 | |
| 3 | 2015 | 43 | |
| 4 | 2021 | 26 | |
| 5 | 2019 | 25 | |
| 6 | 2016 | 14 | |
| 7 | 2022 | 8 | |
| 8 | 2014 | 7 | |
| 9 | 2019 | 5 | |
| 10 | The Antibacterial Effect of Propolis against Clinical Isolates. | 2014 | 5 |
| 11 | 2013 | 5 | |
| 12 | 2023 | 4 | |
| 13 | 2021 | 4 | |
| 14 | 2021 | 4 | |
| 15 | 2025 | 3 | |
| 16 | 2022 | 3 | |
| 17 | 2021 | 3 | |
| 18 | 2019 | 3 | |
| 19 | 2023 | 2 | |
| 20 | 2024 | 2 |
About Ebru Evren
Ebru Evren is a scholar working on Infectious Diseases, Molecular Medicine, Ophthalmology, Clinical Biochemistry and Epidemiology, having authored 32 papers that have together received 293 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (5 papers), Antifungal resistance and susceptibility (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Bacterial Identification and Susceptibility Testing (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Nasolacrimal Duct Obstruction Treatments (3 papers), SARS-CoV-2 detection and testing (3 papers) and Fungal Infections and Studies (2 papers). The work is most often cited by research in Molecular Medicine (77 citations), Applied Microbiology and Biotechnology (23 citations), Microbiology (5 citations), Infectious Diseases (109 citations) and Pharmacology (44 citations). Ebru Evren has collaborated with scholars based in Türkiye, United States and Belgium. Frequent co-authors include Erkan Yurtçu, Hande Arslan, Şule Çolakoğlu, Özlem Kurt Azap, Zeynep Ceren Karahan, Alper Tekelı, İştar Dolapçı, Müge Demirbilek, Ufuk Elgin and Emine Malkoç Şen. Their work appears in journals such as Journal of Materials Chemistry B, Eye & Contact Lens Science & Clinical Practice, Journal of Infection, Analytical Chemistry and Scandinavian Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.